• P-ISSN 2394-9481 E-ISSN 2394-949X

Journal of Medical Sciences and Health

Journal of Medical Sciences and Health

Year: 2026, Volume: 12, Issue: 1, Pages: 55-59

Original Article

Evaluation of Lymph Node Ratio in Oral Squamous Cell Carcinoma and its Association with Pathological Prognostic Parameters: A 5-Year Retrospective Study

Received Date:05 November 2025, Accepted Date:27 January 2026, Published Date:30 March 2026

Creative Commons License

Abstract

Aims & Objectives: To evaluate the lymph node ratio (LNR) in resection specimens of oral squamous cell carcinoma (OSCC) with radical neck dissection and to associate it with various pathological prognostic parameters. 
Materials and Methods: A retrospective observational study conducted over a period of 5 years (December 2018 to December 2023 ) on 62 OSCC patients who underwent resection of primary tumour with radical neck dissection at a tertiary care center. A detailed histopathological evaluation of hematoxylin and eosin stained slides from tumor and lymph nodes was done. LNR is defined as the ratio of positive lymph nodes and the total number of lymph nodes dissected. LNR was calculated and categorised into two groups: <0.068 (low) and ≥0.068 (high) and was statistically analyzed for association with pathological prognostic parameters. 
Result: The mean age of presentation was 55 years with a male-to-female ratio of 5:6. Most patients presented with advanced-stage IV disease, moderately differentiated tumor, and a mean tumor size of 4 cm. Significant associations were found (p < 0.05) between LNR and pT stage, pN stage, TNM stage, and perineural invasion, while no significant association was observed with pathological grade or lymphovascular invasion. Low LNR associated with low nodal stages (N1), whereas high LNR was associated with higher nodal stages (N3). 
Conclusion: LNR is a significant prognostic marker in node-positive OSCC patients and can aid in tailoring adjuvant treatment strategies after curative resection. Its routine evaluation can enhance risk stratification and treatment planning in OSCC management.

Introduction

Head and neck cancer ranks as the sixth most prevalent cancer globally[18]. Oral squamous cell carcinoma (OSCC) constitutes about 90% of all malignancies occurring in the oral cavity, with a global incidence exceeding 350,000 cases, with the highest incidence in India[23]. Despite treatment advances, survival rates remain poor due to cervical lymph node metastasis, the most critical prognostic factor[4].

 

Lymph node ratio (LNR) is defined as the ratio of the number of positive lymph nodes to the total number of lymph nodes dissected , offers improved prognostic accuracy[15-79-12].

The aim of this study was to assess LNR in OSCC resection specimens and its association with pathological markers like pathological T stage (pT), pathological N stage (pN), tumor stage, tumor grade, perineural invasion, and lymphovascular invasion, as there is paucity of such studies in India[13].

Materials and Methods

This retrospective observational study was conducted over a period of 5 years (December  2018 to December 2023) on 62 patients with OSCC  who underwent resection of primary tumour with radical neck dissection, received in the Department of Pathology, at a tertiary care centre. The study was conducted in accordance with the ethical standards given in the 1975 Declaration of Helsinki, as revised in 2000.

 

A detailed histopathological evaluation of hematoxylin and eosin stained slides from tumor and lymph nodes was done. LNR was calculated as the number of pathologically positive lymph nodes divided by the total number of lymph nodes dissected. A validated LNR cut-off of 0.068 reported by Sano D et al., was used,  as their study involved a comparable sample size. LNR was analysed and categorised into two groups [<0.068 (low) and ≥0.068 (high)]. LNR was associated with pathological prognostic parameters like pathological T stage (pT), pathological N stage (pN), tumor stage, tumor grade, perineural invasion and lymphovascular invasion. Pathological staging was performed according to the American Joint Committee on Cancer (8th edition -2017).

Inclusion criteria: 

All patients aged 18 years or older with OSCC who underwent primary tumor resection and radical neck dissection. 

Exclusion criteria: 

Patients with previous neck dissection, prior radiation therapy or chemotherapy, unresectable primary lesion, or multiple primary lesions were excluded from this study. Cases where only biopsy or limited surgery without neck lymph node dissection were excluded from the study. 

Statistical Analysis:

Data was entered into Microsoft Excel data sheet and was analyzed using Statistical Package for Social Sciences [SPSS] windows 22 version (IBM SPSS Statistics, Somers NY, USA) software.  Categorical data was represented in the form of frequencies and proportions. 

Continuous data was represented as mean and standard deviation. Associations between LNR and categorical prognostic parameters were assessed using the Chi-square test or Fisher’s exact test, as appropriate. Correlations were performed with Pearson Correlation coefficient. MS Excel and MS word were used to obtain various types of graphs. 

A p-value <0.05 was considered statistically significant after assuming all the rules of statistical tests. 

Result

The study included 62 cases of  OSCC  in patients who underwent  primary tumour resection along with radical neck dissection. The median age of the patient was 55 years, ranging between 21 to 80 years. The majority of the cohort consisted of female patients (34/62, 55%), with a male:female ratio of 5:6 [Table. 1].

Based on the tumor size majority of patients were diagnosed with pT2 disease (20/62, 32%), with mean tumor size of 4 cm. Cervical node metastasis was predominantly classified as pN2 stage (23/62 , 37% ). All patients are presented with stage III or stage IV disease, the majority being stage IV. Most patients were diagnosed with moderately differentiated grade (80.3%) of OSCC. Among the 62 cases , 20 (32%) exhibited lymphovascular invasion and 39 (63%) demonstrated perineural invasion. The tumor characteristics are detailed in [Table. 2].

Variables

Category 

Number of patients 

Percentage  (%)

Age groups 
(in years )

≥ 40

54

13

<40

8

87

Gender 

Female 

34

55

Male

28

45

Table 1: Age and Gender distribution among the study population

 

Variable

Category 

Number of 
Patients

Percentage 
(%)

Pathological 
T Stage

T1

4

6

T2

20

32

T3

19

31

T4

19

31

Pathological 
N Stage

N1

22

35

N2

23

37

N3

17

27

TNM Stage

III

14

23

IV

16

26

IVA

20

32

IVB

12

19

Perineural Invasion

Absent

42

68

Present

20

32

Lymphovascular Invasion 

Absent

23

37

Present

39

63

Table 2: Distribution of tumor characteristics among the study population

 

The median number of lymph nodes examined was 24, with a range of 6 to 48. The number of positive lymph nodes identified in any specimen ranged from 1 to 9. In most specimens (42 out of 62, 68%), fewer than three positive lymph nodes were identified [Table. 3]. LNR was categorised into 2 groups [<0.068 (low)and ≥ 0.068( high)]. The majority of cases exhibited high LNR (35/62, 56%) [Table. 4].

Total Positive Lymph 
Nodes Isolated

Number of 
Patients 

Percentage 
(%)

<3

42

68

≥3

20

32

Total 

62

100

Table 3: Distribution of total positive lymph nodes isolated among the study population 

 

Lymph node ratio 
(LNR) 

Number of 
patients 

Percentage 
(%)

<0.068

27

44

≥ 0.068

35

56

Total

62

100

Table 4: Distribution of lymph node ratio among the study population

 

Statistical analysis revealed significant association between the LNR and several  pathological parameters [Table. 5], including pT stage (p=0.040), pN stage (p <0.001), TNM stage (p=0.006) and perineural invasion (p=0.035). Notably, low LNR  was associated with lower nodal involvement (N1 stage), whereas high  LNR was associated with higher nodal involvement (N3 stage). However, no significant association was observed between LNR and  pathological grade or lymphovascular invasion.

 

Discussion

The presence of lymph node metastasis in OSCC is known to be the most important prognostic factor and is associated with poor outcome[14]. Identification of metastatic positive lymph nodes is based on quality of neck dissection as well as on the sampling procedure. Limited lymph node dissection or retrieval may result in pathological understaging[15]. Occurrence of positive lymph node is considered in current TNM classification, but no further differentiation is made if more than one lymph node is affected. In this regard , an alternative lymph node staging system is of utmost importance. LNR has gained  importance as an important prognostic factor for several types of tumors, including OSCC[17].

Variable 

Category 

Low LNR 
<0.068

High LNR 
≥ 0.068

Total

P value

Pathological T stage 

T1

3(7%)

1(5%)

4

P=0.040

T2

11(26%)

9(45%)

20

T3

13(31%)

6(30%)

19

T4

15(36%)

4(20%)

19

Total

42(100%)

20(100%)

62

Pathological N Stage 

N1

22(52%)

0(0%)

22

 

P=<0.001

N2

14(33%)

9(47%)

23

N3

6(14%)

11(53%)

17

Total

42(100%)

20(100%)

62

Tumor Stage 

III

14(33%)

0(0%)

14

P=0.006

IV

28(67%)

20(100%)

48

Total

42(100%)

20(100%)

62

Perineural invasion 

Absent

32(76%)

8(42%)

42

 

P=0.035

Present

10(24%)

12(58%)

20

Total

42(100%)

20(100%)

62

Table 5: Association between Lymph node ratio and pathological parameters

 

High incidence rates of OSCC were observed among women in southern India, largely due to the widespread habit of tobacco chewing, which is deeply rooted in the cultural practices of this region. This trend is reflected in our study, where women constituted 55% of the cohort, indicating a female predominance that contrasts with global patterns, where OSCC is more commonly seen in men. The unique lifestyle factors in southern India, including the habitual use of betel quid and other smokeless tobacco products, are likely major contributors to this disparity, highlighting the regional variations in risk factors for OSCC[18].

LNR can be obtained from a simple calculation using pathological records. This may help determine appropriate postoperative treatment for OSCC patients , as many studies with cancer from other solid malignancies such as breast cancer, colon cancer and gastric cancer have shown the prognostic significance of LNR in terms of survival[1920].

In our study, the cutoff for LNR was set at 0.068, consistent with the methodology described by Sano D et al., and divided in two groups: low (LNR <0.068 ) and high (LNR ≥0.068)[13]. Notably, different studies have used varying cutoff limits and criteria for LNR classification, highlighting the absence of a universal standard. For instance, Chen KW et al. categorised LNR into three groups: high (LNR > 0.17), medium (LNR 0.06–0.17), and low (LNR < 0.06)[16]. Similarly, Spoerl S et al. adopted a simpler approach, classifying LNR into two groups: low (<0.05) and high (>0.05)[10]. These variations in cut-off likely arise from differences in study populations, the extent of neck dissection and lymph node yield, statistical approaches used for cut-off determination, disease stage distribution, and geographic population. This highlights the variability in LNR cutoff thresholds across studies which underscores the need for standardized criteria , to enhance the comparability and prognostic utility of LNR [Table. 6].

   

Age

Gender

Range of positive 
lymph nodes excised

Lymph Node ratio
(cut-off)

Association

Present study
N-62

55

F>M

1-9

0.068

pT,pN,TNM,LVI

Sano D et al.
n=63

63

M>F

1-23

0.068

pT,pN

Spoerl S et al.
n=290

60

M>F

1-41

0.055

pT,pN

Chen KW et al.
n= 117

51

M>F

1-15

0.10

Table 6: Comparison of data with various studies

 

Sano D et al. conducted a study involving 63 OSCC patients, with a median age of 63 years and a male-dominant cohort (M > F). Their findings demonstrated significant associations with pT and pN stages. The range of positive lymph nodes excised (1–23) was broader than in our study, potentially reflecting differences in surgical or pathological practices. Notably, the study reported a strong correlation between the number of positive lymph nodes and LNR value (r = 0.953), with higher LNR values indicating greater tumor spread. The authors concluded that LNR serves as a valuable prognostic parameter, strongly associated with pT and pN stages. However, unlike our study, their findings did not extend to associations with TNM staging or lymphovascular invasion (LVI). These differences highlight the variability in study designs and the scope of LNR's prognostic utility [Table. 7][13].

Lymph node ratio (LNR)

Sano D et al.

Present study 

<0.068

37(58%)

27(44%)

≥ 0.068

26(41%)

35(56%)

Number of cases 

63

62

Table 7: Comparison of Lymph node ratio with Sano D et al. and present study 

 

Spoerl S et al. investigated the prognostic value of LNR in OSCC in a study involving 717 patients. Significant associations were observed between LNR and the extent of neck dissection, as well as pT and pN stages. A subset analysis, with a median age of 60 years and a male-predominant cohort, with a broader range of positive lymph nodes excised (1-41). While strong associations with pT and pN stages were noted, no associations with TNM staging or lymphovascular invasion (LVI) were found. The study concluded that LNR is an independent prognostic factor for OSCC, emphasising its importance in stratifying prognosis and the need for standardized cutoff values[10].

Chen KW et al. conducted a study on 117 OSCC patients with a median age of 51 years, predominantly male (M > F), to evaluate the prognostic value of LNR. The range of positive lymph nodes excised was 1–15. The study concluded that LNR is an important prognostic factor for node-positive OSCC patients[16]. 

While our findings align with those of Sano D et al. and Spoerl S et al. in terms of associations with pT and pN stages, the broader associations with TNM stage and LVI in our study suggest that LNR may serve as a more comprehensive prognostic marker when standardized cutoff values are applied. This variability highlights the need for consensus on LNR thresholds and evaluation criteria to enhance its prognostic utility and comparability across studies. This study was limited by its  single-center design and relatively small sample size. Potential variations in neck dissection technique and lymph node retrieval could influence LNR calculation. Follow-up survival data were not analyzed, preventing direct prognostic validation in terms of disease-free or overall survival.

Conclusion

This study highlights the significant association between Lymph Node Ratio (LNR) and various clinical parameters in OSCC, including higher T stage, N stage, advanced TNM stage, and the presence of perineural invasion. By adopting LNR as a prognostic index, treatment strategies could be tailored more effectively. For patients with high LNR, intensifying treatment through the addition of chemotherapy to adjuvant radiotherapy or other advanced approaches may be beneficial. Conversely, lower-risk patients (N1–N2, low LNR) may avoid overtreatment and achieve optimal outcomes with less aggressive therapy. Therefore, we propose that LNR serves as a valuable prognostic marker for guiding treatment decisions in node-positive OSCC patients.

References

1. Sansgiri TS, Saluja H, Shah S, Dadhich A, Singh D. Prognostic Significance of Lymph Node Ratio in Predicting the Outcome of Oral Squamous Cell Carcinoma – A Retrospective StudyAnnals of Maxillofacial Surgery2024; 14 (1). Available from: https://doi.org/10.4103/ams.ams_82_23

2. Struckmeier A-K, Buchbender M, Lutz R, Agaimy A, Kesting M. Comparison of the prognostic value of lymph node yield, lymph node ratio, and number of lymph node metastases in patients with oral squamous cell carcinomaHead &amp; Neck2024; 46 (5). Available from: https://doi.org/10.1002/hed.27748

3. Savitha S, Raj Mohan M, Prabu D, Dinesh D, Sindhu R, Nimmy P. Prevalence Of Oral Cancer In India: A Systematic ReviewIndian Journal of Public Health Research &amp; Development2024; 15 (4). Available from: https://doi.org/10.37506/1yqne619

4. Sundaram GA, Chokkattu J, Krishnan M, Kumar SP, Senthilmurugan M, Lakshman-an S. Lymph Node Ratio as a Prognostic Factor for Oral Tongue Squamous Cell Carcinoma: A Retrospective StudyCureus2023; 15 (8). Available from: https://doi.org/10.7759/cureus.44109

5. Voss JO, Freund L, Neumann F, Mrosk F, Rubarth K, Kreutzer K, <I>et al</I>. Prognostic value of lymph node involvement in oral squamous cell carcinomaClinical Oral Investigations2022; 26 (11). Available from: https://doi.org/10.1007/s00784-022-04630-7

6. Gartagani Z, Doumas S, Kyriakopoulou A, Economopoulou P, Psaltopoulou T, Ko-tsantis I, <I>et al</I>. Lymph Node Ratio as a Prognostic Factor in Neck Dissection in Oral Cancer Patients: A Systematic Review and Meta-AnalysisCancers2022; 14 (18). Available from: https://doi.org/10.3390/cancers14184456

7. Sheppard SC, Frech L, Giger R, Nisa L. Lymph Node Yield and Ratio in Selective and Modified Radical Neck Dissection in Head and Neck Cancer—Impact on Oncological OutcomeCancers2021; 13 (9). Available from: https://doi.org/10.3390/cancers13092205

8. Borse V, Konwar AN, Buragohain P. Oral cancer diagnosis and perspectives in IndiaSensors International2020; 1 Available from: https://doi.org/10.1016/j.sintl.2020.100046

9. Abdeyrim A, He S, Zhang Y, Wang X, Li J, Chen Z, <I>et al</I>. Prognostic value of lymph node ratio in laryngeal and hypopharyngeal squamous cell carcinoma: A systematic review and meta-analysisJournal of Otolaryngology - Head &amp; Neck Surgery2020; 49 (1). Available from: https://doi.org/10.1186/s40463-020-00421-w

10. Spoerl S, Gerken M, Mamilos A, Fischer R, Wolf S, Nieberle F, <I>et al</I>. Lymph node ratio as a predictor for outcome in oral squamous cell carcinoma: a multicenter population-based cohort studyClinical Oral Investigations2021; 25 (4). Available from: https://doi.org/10.1007/s00784-020-03471-6

11. Ding D, Stokes W, Eguchi M, Hararah M, Sumner W, Amini A, <I>et al</I>. Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients With Oral Cavity CancerJAMA Otolaryngology–Head &amp; Neck Surgery2019; 145 (1). Available from: https://doi.org/10.1001/jamaoto.2018.2974

12. Huang TH, Li KY, Choi WS. Lymph node ratio as prognostic variable in oral squamous cell carcinomas: Systematic review and meta-analysisOral Oncology2019; 89 Available from: https://doi.org/10.1016/j.oraloncology.2018.12.032

13. Sano D, Hanai N, Suzuki H, Kimura T, Asakage T, Kamata SE, <I>et al</I>. Lymph node ratio as a prognostic factor for survival in patients with head and neck squamous cell carcinomaAuris Nasus Larynx2018; 45 (4). Available from: https://doi.org/10.1016/j.anl.2017.11.015

14. Talmi YP, Takes RP, Alon EE, Mor C, Shapira B, Horowitz Z, <I>et al</I>. Prog-nostic value of lymph node ratio in head and neck carcinoma. <I>Head & Neck</I>. 2018;1–9.

15. Feng Z, Xu QS, Wang C, Li JZ, Mao MH, Li H, <I>et al</I>. Lymph node ratio is associated with adverse clinicopathological features and is a crucial nodal parameter for oral and oropharyngeal cancerScientific Reports2017; 7 (1). Available from: https://doi.org/10.1038/s41598-017-07134-7

16. Chen CC, Lin JC, Chen KW. Lymph node ratio as a prognostic factor in head and neck cancer patientsRadiation Oncology2015; 10 (1). Available from: https://doi.org/10.1186/s13014-015-0490-9

17. Roberts TJ, Colevas AD, Hara W, Holsinger FC, Oakley-Girvan I, Divi V. Number of positive nodes is superior to the lymph node ratio and <scp>A</scp>merican <scp>J</scp>oint <scp>C</scp>ommittee on <scp>C</scp>ancer <scp>N</scp> staging for the prognosis of surgically treated head and neck squamous cell carcinomasCancer2016; 122 (9). Available from: https://doi.org/10.1002/cncr.29932

18. Varshita A. Prevalence of oral cancer in India. <I>American Journal of Pharmceutical Sciences & Research</I>. 2015;7:845-8.

19. Urban D, Gluck I, Pfeffer MR, Symon Z, Lawrence YR. Lymph node ratio predicts the benefit of post-operative radiotherapy in oral cavity cancerRadiotherapy and Oncology2013; 106 (1). Available from: https://doi.org/10.1016/j.radonc.2012.09.022

20. Ebrahimi A, Clark JR, Zhang WJ, Elliott MS, Gao K, Milross CG, <I>et al</I>. Lymph node ratio as an independent prognostic factor in oral squamous cell carcinomaHead & Neck2011; 33 (9). Available from: https://doi.org/10.1002/hed.21600

DON'T MISS OUT!

Subscribe now for latest articles and news.